The Southern.Wire
← Back to today's edition
Sci & Tech

Anthropic sets its price. The valuation argument is just getting started.

Tech Desk

Anthropic has stopped talking in generalities. The amended filing names a number: 825 million Class A shares, priced at $70 to $78 apiece, with Goldman Sachs and Morgan Stanley steering the book. A trading debut under the ticker ANT is now being pencilled in for the week of 16 November, with some reporting pointing to Wednesday the 19th as the day the opening bell actually rings. Three weeks ago this was a rumoured filing. Now it is a prospectus with a price on it, and that changes the nature of the argument around it.

What hasn't changed is the size of the bet being asked of public markets. Reported valuation chatter has run as high as $2 trillion, a figure that would put a four-year-old AI lab in the same conversation as the handful of companies that have ever reached that mark, none of which got there on a company still burning capital at the rate Anthropic is. The pitch to investors is that revenue has scaled fast enough to outrun the losses — Anthropic's own disclosures point to revenue surging into the tens of billions on an annualised basis even as cumulative losses run far deeper. Whether a public market used to pricing growth against profit timelines will extend AI labs the same patience venture investors have is precisely what this offering is about to test.

The timing carries its own tension. Anthropic is bringing this deal to market in the middle of a broader tech sell-off, the kind of environment that normally pushes issuers to wait rather than price into weakness. That Anthropic is proceeding anyway says something about how much appetite its bankers believe still exists for frontier AI exposure, or how little room there was left to wait. Roughly two dozen banks are reportedly involved in some capacity, a syndicate size that speaks to how much of Wall Street wants a piece of underwriting fees on a deal this size, whatever reservations individual desks might have about the price.

There is a governance wrinkle sitting underneath the headline numbers that deserves more attention than it has received. Reports describing a founder vote structure weighted heavily toward existing control — in the order of fifty to one — would leave public shareholders buying economic exposure to Anthropic's growth while ceding almost all say over its direction to the people who already run it. That is not unusual among tech IPOs built around founder control, but it is a detail that matters more, not less, when the company in question is building systems its own executives routinely describe as consequential enough to need careful handling.

For South African investors watching from a market with no direct equivalent to bid on, the Anthropic listing is a proxy fight by other means: a referendum on whether the AI capital-expenditure cycle of the past three years has produced businesses that can stand on public-market scrutiny, or merely very large, very well-funded private bets that have yet to be tested by a quarterly earnings call. Anthropic is about to find out which one the market believes it is.